Search
Rapid Micro Biosystems Inc
RPIDAdd to Watchlist
1.720USD
+0.010+0.58%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
78.72MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Rapid Micro Biosystems Inc is 8.50, ranking 28 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 8.00, with a high of 8.00 and a low of 8.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
6.667
Target Price
+285.36%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
Rapid Micro Biosystems Inc
RPID
4
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
35
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Rapid Micro Biosystems Inc's expected revenue for the next quarter?
Rapid Micro Biosystems Inc's expected revenue is 7.88M.
What is Rapid Micro Biosystems Inc's price target?
Analysts forecast that Rapid Micro Biosystems Inc's price target is USD 8.00, with the highest forecast at USD 8.00 and the lowest forecast at USD 8.00.
How have Rapid Micro Biosystems IncRPID's recent earnings per share performed?
The market expectation was USD -0.31, while Rapid Micro Biosystems IncRPID's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD -0.24.
What is the analyst rating for Rapid Micro Biosystems Inc?
Based on the ratings of Rapid Micro Biosystems Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.